Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Surgical Nivolumab And Ipilimumab For Recurrent GBM

NCT04606316

Conditions
Astrocytoma, GBM, Glioblastoma, +10 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

NCT04711135

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors, Neoplasms, +7 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Centre Léon Berard Lyon, France
View Trial Details
Active, Not Recruiting

Intratumoral PH-762 for Cutaneous Carcinoma

NCT06014086

Conditions
Malignant Melanoma of Skin, Melanoma, Merkel Cell Carcinoma of Skin, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Paradigm Clinical Research San Diego, California, United States
  • Integrity Research Delray Beach, Florida, United States
  • Skin Cancer and Dermatology Institute Reno, Nevada, United States
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

NCT06190951

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UC San Diego La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions